Therefore, the present study aims to examine the relationship between baseline Hs-CRP levels and all-cause mortality in hospitalized patients with DF complicated by osteoporosis, and to clearly define this association as the primary objective of the study, with the ultimate goal of providing evidence to support more accurate prognostic assessment and individualized management in this high-risk group. The gene discussed is CRP; the disease is osteoporosis.